Conversely, our prior studies also demonstrate that mesenchymal KP lung tumors are more responsive to PD-L1/PD-1 axis immune checkpoint blockade compared with epithelial KP tumors, owing to a ZEB1-mediated upregulation of PD-L1 and other checkpoint proteins in mesenchymal cells9–11. This evidence concerns the gene CD274 and keratosis pilaris.